Marc Odrich
Net worth: 779 572 $ as of 31/05/2026
Net worth: 779 572 $ as of 31/05/2026
Marc Odrich is currently Chief Medical Officer & Director at TearSolutions, Inc., Director at CXL Ophthalmics LLC, Associate Professor at the University of Virginia, and Chief Medical Officer at LENZ Therapeutics, Inc. Formerly, Dr. Odrich was Medical Director at VISX, Inc. Education includes a doctorate from Columbia University College of Physicians & Surgeons.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.32% | 14/04/2026 | 100,202 ( 0.32% ) | 779 572 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural tear generation therapy for dry eyes | Corporate Officer/Principal | - |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Director/Board Member | - |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
VISX, Inc. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural tear generation therapy for dry eyes | Health Technology |
VISX, Inc. | |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Health Services |
Select your edition
All financial news and data tailored to specific country editions